Medicare will begin paying later this year for certain oral cancer drugs and intravenous drugs that can be self-administered under a $500 million demonstration project unveiled yesterday.
Medicare is spending $500 billion on the new project.
( z1 spend :ARG0 ( z2 program :name ( z3 name :op "Medicare" ) ) :ARG1 ( z4 project :ARG1-of ( z5 new ) ) :ARG3 ( z6 monetary-quantity :quant 500000000000 :unit ( z7 dollar ) ) )